Brand name | Nonproprietary Name | Authorization date | Marketing authorisation holder |
---|---|---|---|
Opdivo | nivolumab | 2015-06-19 | Bristol-Myers Squibb Pharma EEIG |
Nivolumab BMS | nivolumab | 2015-07-20 | Bristol-Myers Squibb Pharma EEIG |
EMA:Drugs approved by European Medicines Agency through centralized Procedure.
HMA:Drugs approved by EU members through Mutual Recognition Procedure.
For more information check in official website of members:
Brand name | Nonproprietary Name | Authorization date | Marketing authorisation holder |
---|---|---|---|
Opdivo | nivolumab | 2015-06-19 | Bristol-Myers Squibb Pharma EEIG |
Nivolumab BMS | nivolumab | 2015-07-20 | Bristol-Myers Squibb Pharma EEIG |